Organization of the ENaC-regulatory Machinery
Overview
Molecular Biology
Authors
Affiliations
The control of fluid and electrolyte homeostasis in vertebrates requires the integration of a diverse set of signaling inputs, which control epithelial Na(+) transport, the principal ionic component of extracellular fluid. The key site of regulation is a segment of the kidney tubules, frequently termed the aldosterone-sensitive distal nephron, wherein the epithelial Na(+) channel (or ENaC) mediates apical ion entry. Na(+) transport in this segment is strongly regulated by the salt-retaining hormone, aldosterone, which acts through the mineralocorticoid receptor (MR) to influence the expression of a selected set of target genes, most notably the serine-threonine kinase SGK1, which phosphorylates and inhibits the E3 ubiquitin ligase Nedd4-2. It has long been known that ENaC activity is tightly regulated in vertebrate epithelia. Recent evidence suggests that SGK1 and Nedd4-2, along with other ENaC-regulatory proteins, physically associate with each other and with ENaC in a multi-protein complex. The various components of the complex are regulated by diverse signaling networks, including steroid receptor-, PI3-kinase-, mTOR-, and Raf-MEK-ERK-dependent pathways. In this review, we focus on the organization of the targets of these pathways by multi-domain scaffold proteins and lipid platforms into a unified complex, thereby providing a molecular basis for signal integration in the control of ENaC.
ENaCγ in Urinary Extracellular Vesicles as an Indicator of MR Signaling in Primary Aldosteronism.
Hayama Y, Kuribayashi-Okuma E, Fujii N, Ochiai-Homma F, Yamazaki O, Tsurutani Y Hypertension. 2024; 81(12):2457-2467.
PMID: 39319458 PMC: 11578056. DOI: 10.1161/HYPERTENSIONAHA.124.23379.
Submersion and hypoxia inhibit alveolar epithelial Na transport through ERK/NF-κB signaling pathway.
Zhou W, Hou Y, Yu T, Wang T, Ding Y, Nie H Respir Res. 2023; 24(1):117.
PMID: 37095538 PMC: 10127099. DOI: 10.1186/s12931-023-02428-z.
Aldosterone: Renal Action and Physiological Effects.
Johnston J, Welch A, Cain B, Sayeski P, Gumz M, Wingo C Compr Physiol. 2023; 13(2):4409-4491.
PMID: 36994769 PMC: 11472823. DOI: 10.1002/cphy.c190043.
Wall S Hypertension. 2022; 79(4):706-716.
PMID: 35109661 PMC: 8918038. DOI: 10.1161/HYPERTENSIONAHA.121.16492.
Li J, Liu L, Zhou X, Lu X, Liu X, Li G Front Pharmacol. 2020; 11:590652.
PMID: 33362546 PMC: 7759566. DOI: 10.3389/fphar.2020.590652.